Baidu
map

自身免疫性溶血性贫血诊疗指南 (2022年版)

2022-04-11 中华人民共和国国家卫生健康委员会 卫健委官网

自身免疫性溶血性贫血( Autoimmune Hemolytic Anemia,AIHA)是免疫功能异常导致 B 细胞功能亢进产生自身红细胞的抗体,红细胞吸附自身抗体和/或补体,致使红细胞破坏加速、寿

中文标题:

自身免疫性溶血性贫血诊疗指南 (2022年版)

发布日期:

2022-04-11

简要介绍:

自身免疫性溶血性贫血( Autoimmune Hemolytic Anemia,AIHA)是免疫功能异常导致 B 细胞功能亢进产生自身红细胞的抗体,红细胞吸附自身抗体和/或补体,致使红细胞破坏加速、寿命缩短的一组溶血性贫血。国外资料显示 AIHA 的年发病率为(0.8-3.0)/10 万。根据自身抗体与红细胞最适反应温度,AIHA 可分为温抗体型(37℃,占 60%~ 80%)、冷抗体型(20℃,占 20%~30%)和温冷抗体混合型 (约占 5%)。AIHA 分为原发性和继发性。约 50%的温抗体型 AIHA 为继发性,可继发于造血及淋巴细胞增殖性疾病,如慢 性淋巴细胞白血病、非霍奇金淋巴瘤、霍奇金淋巴瘤、 Castleman 病、骨髓纤维化等、实体瘤、免疫性疾病、感染、药物、原发免疫缺陷病、妊娠以及异基因造血干细胞移植后等。

相关资料下载:
[AttachmentFileName(sort=1, fileName=自身免疫性溶血性贫血诊疗指南 (2022年版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=4fb591c002a11eee, title=自身免疫性溶血性贫血诊疗指南 (2022年版), enTitle=, guiderFrom=卫健委官网, authorId=0, author=, summary=自身免疫性溶血性贫血( Autoimmune Hemolytic Anemia,AIHA)是免疫功能异常导致 B 细胞功能亢进产生自身红细胞的抗体,红细胞吸附自身抗体和/或补体,致使红细胞破坏加速、寿, cover=https://img.medsci.cn/20220414/1649879501668_5579292.jpg, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 11 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #000000;">自身免疫性溶血性贫血( Autoimmune Hemolytic Anemia,AIHA)是免疫功能异常导致 B 细胞功能亢进产生自身红细胞的抗体,红细胞吸附自身抗体和/或补体,致使红细胞破坏加速、寿命缩短的一组溶血性贫血。国外资料显示 AIHA 的年发病率为(0.8-3.0)/10 万。根据自身抗体与红细胞最适反应温度,AIHA 可分为温抗体型(37℃,占 60%~ 80%)、冷抗体型(20℃,占 20%~30%)和温冷抗体混合型 (约占 5%)。AIHA 分为原发性和继发性。约 50%的温抗体型 AIHA 为继发性,可继发于造血及淋巴细胞增殖性疾病,如慢 性淋巴细胞白血病、非霍奇金淋巴瘤、霍奇金淋巴瘤、 Castleman 病、骨髓纤维化等、实体瘤、免疫性疾病、感染、药物、原发免疫缺陷病、妊娠以及异基因造血干细胞移植后等。</span></p>, tagList=[TagDto(tagId=47687, tagName=自身免疫性溶血性贫血), TagDto(tagId=117103, tagName=淋巴|免疫)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9284, appHits=412, showAppHits=0, pcHits=1107, showPcHits=8872, likes=3, shares=95, comments=3, approvalStatus=1, publishedTime=Thu Apr 14 15:38:00 CST 2022, publishedTimeString=2022-04-11, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Apr 14 03:56:21 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 18:53:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=自身免疫性溶血性贫血诊疗指南 (2022年版).pdf)])
自身免疫性溶血性贫血诊疗指南 (2022年版).pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214805, encodeId=68d11214805be, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:14:47 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212049, encodeId=3f841212049e8, content=很好的平台,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ae36554021, createdName=ms7000000104093685, createdTime=Mon Apr 18 00:07:24 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212047, encodeId=cc01121204eb7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ae36554021, createdName=ms7000000104093685, createdTime=Mon Apr 18 00:05:10 CST 2022, time=2022-04-18, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214805, encodeId=68d11214805be, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:14:47 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212049, encodeId=3f841212049e8, content=很好的平台,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ae36554021, createdName=ms7000000104093685, createdTime=Mon Apr 18 00:07:24 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212047, encodeId=cc01121204eb7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ae36554021, createdName=ms7000000104093685, createdTime=Mon Apr 18 00:05:10 CST 2022, time=2022-04-18, status=1, ipAttribution=)]
    2022-04-18 ms7000000104093685

    很好的平台,受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214805, encodeId=68d11214805be, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:14:47 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212049, encodeId=3f841212049e8, content=很好的平台,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ae36554021, createdName=ms7000000104093685, createdTime=Mon Apr 18 00:07:24 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212047, encodeId=cc01121204eb7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ae36554021, createdName=ms7000000104093685, createdTime=Mon Apr 18 00:05:10 CST 2022, time=2022-04-18, status=1, ipAttribution=)]
    2022-04-18 ms7000000104093685

    很好

    0

Baidu
map
Baidu
map
Baidu
map